Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. is a rapidly developing new drug R & D service and API manufacturer. Since its establishment in December 2007, with scientific and technological innovation as the driving force and the goal of creating a characteristic "intelligent" innovation enterprise, the company has actively carried out all-round cooperation with customers and business partners, and strive to become a leading enterprise in the research, production and sales of new drug creation services and API process innovation. Hongbo pharmaceutical headquarters is located in the east area of Zhangjiang High tech Industrial Park, Pudong New Area, Shanghai, with about 11100 square meters of office area, laboratory and advanced instruments and equipment. Since its inception, the company has focused on creating a safe, comfortable and scientific working environment for employees. At present, the company has NMR (Bruker 400m), SFC, HPLC, chiral HPLC, LC-MS, LC-MS / MS (API 4000), IR, UV, GC, GC-MS, forward / reverse phase preparation chromatography, microwave synthesizer, parallel synthesizer Differential scanning calorimeter (DSC), electron microscope and other experimental and testing equipment. It is such a high-quality scientific research environment that ensures the high-quality operation and scientific research achievements of Hongbo pharmaceutical R & D department. As a high-tech enterprise, the company has so far obtained 23 domestic and foreign patents, including 22 domestic patents and 1 American patent. Hongbo Zhiyuan, located in Kaiyuan city, Liaoning Province (Kaiyuan) pharmaceutical, as a production base, covers an area of 60000 square meters. It has plants, equipment, facilities and inspection systems that meet the current GMP standards. It is mainly engaged in the R & D, production and sales of international cutting-edge high-end chemical APIs and intermediates. Its existing products include tigritol, pramivir, vapatavir, sofibovir, etc., and has obtained the EU cos certificate and many other certificates It is an international high-end certification and has long-term cooperation with Novartis, Sanofi, chemo, Teva, Dr Reddy, Cipla and other well-known foreign enterprises, which has great potential for rapid development.